Second-line Chemotherapy for Advanced Bladder Cancer: Taxanes Versus Vinflunine
Aim: Second-line chemotherapy in advanced urothelial carcinoma (UC) remains a significant clinical challenge, with limited high-level evidence guiding regimen selection. Vinflunine is the only agent approved by the European Medicines Agency for this setting, while taxanes are widely used off-label b...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ankara Hematology Oncology Association
2025-08-01
|
| Col·lecció: | Acta Haematologica Oncologica Turcica |
| Matèries: | |
| Accés en línia: | https://www.actaoncologicaturcica.com/articles/second-line-chemotherapy-for-advanced-bladder-cancer-taxanes-versus-vinflunine/doi/ahot.galenos.2025.2025-7-2 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|